Imiquimod for scc

org In this controlled trial, patients with cutaneous SCC in situ receiving topical imiquimod 5% cream as monotherapy experienced a high degree of clinical benefit compared with placebo. RESULTS A total of 861 patients with 1,198 cSCCIS were treated, with median follow-up of 71 months

2024-03-28
    Advanced clinicals vitamin c percentage
  1. C
  2. It is in the immune modulator class of drugs
  3. SCOPE
  4. Some crusting and swelling may also occur